The Defense Department invests more than $40 million a year in medical research programs that aim to develop vaccines or drugs for treating antibiotic-resistant infections, Military Times reported Sunday.
“We try to identify these technologies, new products … and be able to provide some funding for investigators so they can flesh out whether it’s going to be successful,” said Col. Michael Kozar, a program director at the Army‘s Medical Research and Materiel Command, according to Military Times.
Patricia Kime writes a Pentagon report indicates that one in 10 military recruits acquires a skin infection that prevents them from continuing their training or leads to service discharge.
The Walter Reed Army Institute of Research has obtained funding to explore the potential of small molecules in killing bacteria, according to Military Times.
Kime reports the Uniformed Services University of the Health Sciences embarked on a clinical study to monitor service members who got injured or sick during the recent wars.
“What we’re trying to do is be prepared, do the research, get the countermeasures,” Kozar added, according to Kime’s article.
The President’s Council of Advisors on Science and Technology will endorse a plan to create a task force that will study antimicrobial resistance and to incentivize drug companies’ antibiotic development efforts, Kime writes.